{
    "Trade/Device Name(s)": [
        "Optilite High Sensitivity C-Reactive Protein Kit",
        "Optilite\u00ae High Sensitivity C-Reactive Protein Kit"
    ],
    "Submitter Information": "The Binding Site Group Ltd",
    "510(k) Number": "K180099",
    "Predicate Device Reference 510(k) Number(s)": [
        "K053603"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DCN"
    ],
    "Summary Letter Date": "August 29, 2018",
    "Summary Letter Received Date": "September 4, 2018",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.5270"
    ],
    "Regulation Name(s)": [
        "C-reactive protein immunological test system"
    ],
    "Analyte Class(es)": [
        "immunology",
        "chemistry"
    ],
    "Analyte(s)": [
        "C-Reactive Protein"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Binding Site Optilite analyser"
    ],
    "Method(s)/Technology(ies)": [
        "Immunoturbidimetry",
        "Turbidimetry"
    ],
    "Methodologies": [
        "Quantitative measurement",
        "Turbidimetric immunoassay"
    ],
    "Submission Type(s)": [
        "Kit",
        "Reagent",
        "Calibrator",
        "Control",
        "Buffer"
    ],
    "Document Summary": "FDA 510(k) summary for Optilite High Sensitivity C-Reactive Protein Kit, a quantitative immunoturbidimetric assay for measuring C-reactive protein in serum using the Optilite analyser.",
    "Indications for Use Summary": "Intended for quantitative in vitro measurement of C-Reactive Protein in serum to evaluate conditions associated with inflammation in otherwise healthy individuals, used with other laboratory and clinical findings.",
    "fda_folder": "Immunology"
}